# An Observational Study to Assess the Burden of Drug-resistant Partial Epilepsy in Italy

> **NCT01332539** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 240 (actual)

## Conditions studied

- Epilepsy, Partial

## Interventions

- **OTHER:** no intervention

## Key facts

- **NCT ID:** NCT01332539
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2013-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01332539

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01332539, "An Observational Study to Assess the Burden of Drug-resistant Partial Epilepsy in Italy". Retrieved via MORVS 2026-09-29 from https://api.morvs.ai/clinical/NCT01332539. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*